The FXR agonist, GW4064, was found to suppress HCC in cell culture and a xenograft model through alterations in suppressor of cytokine signaling 3 (SOCS3), a major repressor of the signal transducer and activator of transcription 3 (STAT3) pathway [172]. This evidence concerns the gene NR1H4 and hepatocellular carcinoma.